Humana Inc. (NYSE:HUM) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday.

Several other equities analysts have also weighed in on HUM. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $253.00 price objective on the stock in a research note on Thursday, May 18th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $230.00 price objective (up from $221.00) on shares of Humana in a research note on Thursday, May 4th. Evercore ISI reaffirmed an “outperform” rating and issued a $240.00 price objective on shares of Humana in a research note on Tuesday, April 25th. CIBC reaffirmed an “outperform” rating on shares of Humana in a research note on Thursday, March 30th. Finally, Deutsche Bank AG reduced their price objective on Humana from $234.00 to $216.00 and set a “hold” rating on the stock in a research note on Wednesday, May 10th. Eight research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $223.16.

Analyst Recommendations for Humana (NYSE:HUM)

Humana (NYSE:HUM) traded up 1.69% on Tuesday, reaching $231.95. 1,318,891 shares of the company’s stock were exchanged. The company has a market capitalization of $33.47 billion, a PE ratio of 23.64 and a beta of 0.90. The company has a 50 day moving average price of $228.84 and a 200-day moving average price of $212.85. Humana has a 1-year low of $150.00 and a 1-year high of $236.35.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.20. Humana had a return on equity of 14.38% and a net margin of 2.71%. The firm had revenue of $13.76 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same period last year, the company earned $1.86 EPS. On average, equities research analysts anticipate that Humana will post $11.15 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 31st. Shareholders of record on Friday, June 30th will be issued a dividend of $0.40 per share. The ex-dividend date is Wednesday, June 28th. This represents a $1.60 annualized dividend and a yield of 0.69%. Humana’s dividend payout ratio is presently 16.24%.

COPYRIGHT VIOLATION WARNING: This article was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/06/13/humana-inc-hum-downgraded-by-bidaskclub-to-hold.html.

In other Humana news, CEO Bruce D. Broussard sold 118,231 shares of Humana stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $225.82, for a total transaction of $26,698,924.42. Following the sale, the chief executive officer now directly owns 171,170 shares in the company, valued at approximately $38,653,609.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jody L. Bilney sold 4,348 shares of Humana stock in a transaction that occurred on Tuesday, March 21st. The stock was sold at an average price of $213.80, for a total value of $929,602.40. Following the sale, the senior vice president now owns 13,578 shares in the company, valued at $2,902,976.40. The disclosure for this sale can be found here. Insiders have sold a total of 142,618 shares of company stock worth $32,183,465 over the last 90 days. 0.80% of the stock is owned by company insiders.

Large investors have recently bought and sold shares of the company. Thrivent Financial for Lutherans increased its stake in Humana by 6.3% in the fourth quarter. Thrivent Financial for Lutherans now owns 6,065 shares of the insurance provider’s stock valued at $1,235,000 after buying an additional 360 shares in the last quarter. Baldwin Brothers Inc. MA increased its stake in Humana by 2.7% in the first quarter. Baldwin Brothers Inc. MA now owns 67,441 shares of the insurance provider’s stock valued at $13,902,000 after buying an additional 1,782 shares in the last quarter. A.R.T. Advisors LLC acquired a new stake in Humana during the fourth quarter valued at about $3,427,000. Bain Capital Public Equity Management LLC acquired a new stake in Humana during the fourth quarter valued at about $35,079,000. Finally, Guggenheim Capital LLC increased its stake in Humana by 51.0% in the fourth quarter. Guggenheim Capital LLC now owns 262,580 shares of the insurance provider’s stock valued at $53,574,000 after buying an additional 88,685 shares in the last quarter. Institutional investors own 98.95% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.